How should hypotension be managed in an 88-year-old woman with hypertension on olmesartan (angiotensin II receptor blocker), hydrochlorothiazide (thiazide diuretic), and labetalol (beta‑blocker/alpha‑blocker), who recently completed a 5‑day prednisone course for a right‑ear infection and now presents with worsening headache, ear burning, and a blood pressure of 85/45 mm Hg?

Immediate Management of Hypotension in an 88-Year-Old on Triple Antihypertensive Therapy

Stop all three antihypertensive medications immediately (olmesartan, hydrochlorothiazide, and labetalol) and provide IV fluid resuscitation with normal saline to stabilize this patient's blood pressure of 85/45 mmHg.

Critical Assessment

This patient presents with symptomatic hypotension (BP 85/45 mmHg) in the setting of:

• Triple antihypertensive therapy (ARB + thiazide diuretic + beta-blocker/alpha-blocker)
• Recent prednisone course (just completed 5 days ago)
• Advanced age (88 years old)
• Concerning symptoms (worsening headache, ear burning)

Immediate Concerns

The combination of recent corticosteroid discontinuation and ongoing triple antihypertensive therapy has created a volume-depleted, hypotensive state. The olmesartan FDA label explicitly warns that "in patients with an activated renin-angiotensin-aldosterone system, such as volume- and/or salt-depleted patients (e.g., those being treated with high doses of diuretics), symptomatic hypotension may be anticipated" 1. The label specifically recommends: "If hypotension does occur, place the patient in the supine position and, if necessary, give an intravenous infusion of normal saline" 1.

Step-by-Step Management Algorithm

Phase 1: Acute Stabilization (First 24-48 Hours)

1. Discontinue all antihypertensives immediately

   • Hold olmesartan, hydrochlorothiazide, and labetalol
   • Do not restart until BP stabilizes above 100/60 mmHg consistently

2. IV fluid resuscitation

   • Administer normal saline bolus (250-500 mL initially)
   • Monitor response and repeat as needed
   • Place patient supine as recommended by FDA labeling 1

3. Monitor for orthostatic hypotension

   • Check BP supine and standing (if safe to do so)
   • The 2024 ESC guidelines specifically identify patients aged ≥85 years and those with symptomatic orthostatic hypotension as requiring special consideration for slower medication titration 2

Phase 2: Identify Contributing Factors

Prednisone withdrawal effect: The recent completion of a 5-day prednisone course may have caused:

• Relative adrenal suppression
• Volume contraction as corticosteroid effect wanes
• Enhanced hypotensive response to existing antihypertensive medications

Volume depletion from diuretic: Hydrochlorothiazide in combination with recent steroid withdrawal creates a high-risk scenario for symptomatic hypotension 1.

Polypharmacy in elderly: Research demonstrates that "the combination of three antihypertensive agents including a beta-blocker induces more frequently orthostatic hypotension" in elderly hypertensive patients 3.

Phase 3: Medication Reassessment (After BP Stabilization)

Once BP stabilizes (typically 48-72 hours after holding medications):

1. Do NOT restart all three medications

   • At age 88, this patient was likely overtreated
   • The 2024 ESC guidelines recommend exceptions to combination therapy for "patients aged ≥85 years, those with symptomatic orthostatic hypotension, moderate-to-severe frailty" 2

2. Restart with monotherapy or dual therapy at most

   • Begin with a single agent (ARB or calcium channel blocker preferred)
   • Avoid restarting the thiazide diuretic initially given volume depletion risk
   • Consider avoiding labetalol given its association with orthostatic hypotension in elderly patients 4

3. Target BP for this age group

   • For an 88-year-old, aim for BP <150/90 mmHg initially
   • Avoid aggressive targets that increase fall risk and hypotension
   • Monitor standing BP at every visit

Phase 4: Long-Term Considerations

Medication selection going forward:

• If restarting therapy, use single-pill combination of ARB + calcium channel blocker (avoiding diuretic)
• The 2024 ESC guidelines state: "slower up-titration, and lower dosing should be considered in the setting of...older people (aged ≥85 years)" 2
• Beta-blockers like labetalol should be avoided unless there are compelling indications (heart failure, post-MI, angina) 2

Critical monitoring:

• Check orthostatic vital signs at every visit
• Assess for symptoms of dizziness, falls, or syncope
• Monitor renal function and electrolytes given ARB use 1

Common Pitfalls to Avoid

1. Do not restart all medications simultaneously - This is the most common error and will likely reproduce the hypotensive crisis

2. Do not assume this is "just dehydration" - While volume depletion contributes, the underlying issue is medication overtreatment in an elderly patient

3. Do not aggressively treat hypertension in very elderly patients - The evidence supports more conservative BP targets in patients >85 years 2, 5

4. Do not ignore the prednisone timing - Recent steroid discontinuation can unmask relative volume depletion and enhance hypotensive medication effects

5. Do not restart thiazide diuretic as first agent - This perpetuates volume depletion risk; if diuretic needed later, use lowest dose

Addressing the Headache and Ear Symptoms

While managing hypotension, investigate whether:

• Headache represents hypotension-related cerebral hypoperfusion (should improve with BP normalization)
• Ear infection is adequately treated or requires further intervention
• Symptoms could represent other pathology requiring workup once hemodynamically stable

The priority remains hemodynamic stabilization first, as hypotension at 85/45 mmHg poses immediate risk of end-organ hypoperfusion, falls, and syncope in an 88-year-old patient.